Fluoride

Fluoride

SCHEMBL384318

CCN(S)CC.F.F.F

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fluoride SCHEMBL10788206 1.00
Fluoride SCHEMBL337023 1.00 ABCB11 (0.30)
SCHEMBL384317 0.95
Ethane SCHEMBL2526199 0.91
Propane SCHEMBL2521863 0.91
SCHEMBL28950638 0.91
Ethane SCHEMBL4578616 0.87
Butane SCHEMBL2524930 0.87
Fluoride SCHEMBL28981522 0.86
Dimethyl Sulfoxide SCHEMBL5667863 0.83

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020243153-A1 FUSED HETEROCYCLIC DERIVATIVES Janssen Sciences Ireland Unlimited Company (IE) 2020-12-03 WO claimed
CN-111278809-B Bicyclic sulfones and sulfoxides, and methods of use thereof 豪夫迈·罗氏有限公司 2024-06-25 CN disclosed
EP-4236963-A1 5ALPHA-HYDROXY-6BETA-[2-(1-H-IMIDAZOL-4-YL)-ETHYLAMINO]-CHOLESTAN-3BETA-OL ANALOGUES AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME FOR USE IN THE TREATMENT OF CANCER Dendrogenix (BE) 2023-09-06 EP disclosed
CN-115702024-A Difluorocyclohexyl derivatives as IL-17 modulators UCB生物制药有限责任公司 2023-02-14 CN disclosed
CN-109641854-B Modulators of integrated stress pathways 卡里科生命科学有限责任公司 2023-02-03 CN disclosed
CN-115066418-A Carboxy derivatives with anti-inflammatory properties 西特瑞治疗有限公司 2022-09-16 CN disclosed
CN-115003296-A Compounds and methods for treating cystic fibrosis 弗拉特利发现实验室有限责任公司 2022-09-02 CN disclosed
CN-114555585-A HPK1 inhibitors and uses thereof 上海齐鲁锐格医药研发有限公司 2022-05-27 CN disclosed
WO-2022090427-A1 5ALPHA-HYDROXY-6BETA-[2-(1-H-IMIDAZOL-4-YL)-ETHYLAMINO]-CHOLESTAN-3BETA-OL ANALOGUES AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME FOR USE IN THE TREATMENT OF CANCER DENDROGENIX (BE) 2022-05-05 WO disclosed
WO-2020243153-A1 FUSED HETEROCYCLIC DERIVATIVES Janssen Sciences Ireland Unlimited Company (IE) 2020-12-03 WO disclosed
US-5750553-A ANTIANDROGENIC AGENTS ROUSSEL UCLAF (FR) 1998-05-12 US disclosed
US-5434175-A PARASITICIDES, INSECTICIDES AND MITICIDES ROUSSEL UCLAF (FR) 1995-07-18 US disclosed
US-5428043-A Tricyclic-cyclic amines as novel cholinesterase inhibitors PFIZER INC. (US) 1995-06-27 US disclosed
US-5395845-A Insecticides ROUSSEL-UCLAF (FR) 1995-03-07 US disclosed
US-5340835-A Insecticides ROUSSEL-UCLAF (FR) 1994-08-23 US disclosed
US-5310746-A Insecticides, miticides, nematocides ROUSSEL UCLAF (FR) 1994-05-10 US disclosed
US-5086047-A Controlling estrogen production; breast cancer ROUSSEL UCLAF, DEPARTMENT DES BREVETS (FR) 1992-02-04 US disclosed
CN-1054600-A New anticholinesterase three ring-cyclammonium PFIZER (US) 1991-09-18 CN disclosed
EP-0441517-A2 Tricyclic amines as novel cholinesterase inhibitors PFIZER INC. (US) 1991-08-14 EP disclosed
US-4988684-A Steroids for the inhibition of aromatase for the treatment of cancer ROUSSEL UCLAF (FR) 1991-01-29 US disclosed